Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth

The objective of the Together on Diabetes study is to test the efficacy of a pilot intervention to improve the prevention and management of type 2 diabetes among American Indian youth.

The primary aim of this study is to determine the impact of the Together on Diabetes pilot intervention on youth diabetes risk behaviors, including:

  • Improvement in youth dietary intake, with a specific focus on reducing the percent of total calories from fat.
  • Improvement in youth physical activity, with a specific focus on increasing the number of minutes of physical activity each week.

An additional primary aim of the study is to determine the feasibility and acceptability of the pilot intervention and evaluation, including program adherence and program satisfaction.

The secondary aim of this study is to determine the feasibility of collecting data to determine program impact on a number of physiological measures.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a single group pre-post study designed to evaluate the feasibility and effectiveness of a pilot intervention at improving the prevention and management of type 2 diabetes among American Indian youth. The intervention uses a Family Health Coach model to work with families of youth with diabetes or at high risk of diabetes. Health Coaches visit families in their homes and conduct intervention sessions with both youth and a designated adult 'support person' (e.g., parent, guardian, etc). For Youth Participants, the pilot intervention consists of 12 sessions (45-60 minutes in duration) delivered during a 6-month intervention phase, plus 6 check-ins delivered during a 6-month follow-up phase. There are also 4 optional social support visits for the Youth Participants in order to provide necessary assistance with challenges the youth may be facing. For Support Persons, the pilot intervention consists of 4 family skill building sessions (20-30 minutes in length) delivered during the first 4 months of the Youth Participant's intervention phase. Support Persons will also be welcomed and encouraged to attend any of the Youth Participant sessions. All sessions are designed to be taught at the participant's home, but they may also occur at another location chosen by the participant (e.g. school, study office, clinic). Outcome data will be collected at Baseline, 3 months following Baseline, 6 months following Baseline, and 12 months following Baseline.

Study Type

Interventional

Enrollment (Actual)

506

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21205
        • Johns Hopkins Center for American Indian Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

(YOUTH PARTICIPANT) --

  • American Indian youth aged 10-19 years old at enrollment
  • Resides within 1-hour transportation range (~ 50 miles) of the participating Indian Health Service (IHS) medical facilities (Tuba City, Arizona; Chinle, Arizona; Shiprock, New Mexico; Whiteriver, Arizona).
  • Parent/guardian consent for youth under 18 years old.
  • Referral from an Indian Health Services provider indicating a diagnosis by laboratory test of type 2 diabetes or pre-diabetes OR considered at-risk for type 2 diabetes based on BMI ≥ 85th percentile and qualifying lab test

(SUPPORT PERSON) --

  • Adults 18 years of age or older
  • Identified on the Youth Participant consent form as the preferred Support Person to be enrolled in the program
  • Living with the enrolled Youth Participant or within 15 miles of the youth

Exclusion Criteria:

(YOUTH PARTICIPANT)

  • Females who are pregnant or nursing or are planning to become pregnant within one year of enrollment
  • Diabetes due to secondary causes, such as exogenous steroids, Cushing's, or Cystic Fibrosis
  • Youth with type 1 diabetes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Together on Diabetes-Hopkins
The Johns Hopkins Center for American Indian Health, with support from Bristol-Myers Squibb Foundation, Inc. is adapting a Family Health Coach model for diabetes prevention with four southwestern tribal communities. Specifically, Johns Hopkins Center for American Indian Health has designed a paraprofessional delivered pilot intervention aimed at improving the prevention and management of type 2 diabetes among American Indian youth. For Youth Participants, the pilot intervention consists of 12 sessions delivered during a 6-month intervention phase, plus 6 check-ins delivered during a 6-month follow-up phase. For Support Persons, the pilot intervention consists of 4 family skill building sessions delivered during the first 4 months of the Youth Participant's intervention phase.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in percent of total calories from fat from baseline through 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
Increased physical activity levels between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Decreased body mass index between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Improvement in point of care Hemoglobin A1C level between baseline and 12 month follow-up
Time Frame: 12 months follow-up
12 months follow-up
Decrease in waist circumference between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Decreased blood pressure between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Improvements in youth diabetes knowledge test score between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Improved score on Pediatric quality of life assessment (Ped-QL) between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Increased numbers of family members involved in diabetes support care between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up
Increased numbers of individuals having been screen for diabetes between baseline and 12 months follow-up
Time Frame: 12 months follow-up
12 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Allison Barlow, MPH, MA, Johns Hopkins Bloomberg School of Public Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

July 17, 2013

First Submitted That Met QC Criteria

July 25, 2013

First Posted (Estimate)

July 30, 2013

Study Record Updates

Last Update Posted (Actual)

March 20, 2017

Last Update Submitted That Met QC Criteria

March 16, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Together on Diabetes - JHSPH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on Together on Diabetes-Hopkins

3
Subscribe